A TargetMI consortium meeting was held in Leiden on 18 March 2026, hosted by Leiden University Medical Center. The meeting focused on project updates, data analysis, and planning of next steps.
Stephanie Bezzina Wettinger presented an overview of the current project status.
Matthew Vella presented 10-year follow-up data from the MAMI Study, including applications of sPLS-DA and PLS-DA.
Britte van der Vliet and Bart van Vlijmen presented progress on biomarker assay development using LC-MS/MS.
Diego Agius presented results from differential expression analysis of untargeted proteomics data.
Yesahel Scicluna presented work on case stratification.
Frits Rosendaal, Astrid van Hylckama Vlieg, Eleonora Camilleri, and Rosienne Farrugia contributed to discussions on future directions and continuation of the TargetMI project.
